316 related articles for article (PubMed ID: 10965656)
21. [Prospective therapy study in differentiated thyroid carcinoma].
Gemsenjäger E; Heitz P; Martina B
Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
[TBL] [Abstract][Full Text] [Related]
22. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
Min JJ; Chung JK; Lee YJ; Jeong JM; Lee DS; Jang JJ; Lee MC; Cho BY
Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
[TBL] [Abstract][Full Text] [Related]
23. Management of intracranial metastases of differentiated carcinoma of thyroid.
Biswal BM; Bal CS; Sandhu MS; Padhy AK; Rath GK
J Neurooncol; 1994; 22(1):77-81. PubMed ID: 7714554
[TBL] [Abstract][Full Text] [Related]
24. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
[TBL] [Abstract][Full Text] [Related]
25. The effects of radioactive iodine in thyroid remnant ablation and treatment of well differentiated thyroid carcinoma.
Lin JD; Kao PF; Chao TC
Br J Radiol; 1998 Mar; 71(843):307-13. PubMed ID: 9616241
[TBL] [Abstract][Full Text] [Related]
26. Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine.
Pacini F; Cetani F; Miccoli P; Mancusi F; Ceccarelli C; Lippi F; Martino E; Pinchera A
World J Surg; 1994; 18(4):600-4. PubMed ID: 7725751
[TBL] [Abstract][Full Text] [Related]
27. Solitary brain metastasis from papillary thyroid carcinoma in a patient with depression: report of a case.
Maruyama M; Kobayashi S; Shingu K; Nagashima H; Nagamine K; Kasuga Y; Kato R; Kameko F; Amano J
Surg Today; 2000; 30(9):827-30. PubMed ID: 11039712
[TBL] [Abstract][Full Text] [Related]
28. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.
Menzel C; Grünwald F; Schomburg A; Palmedo H; Bender H; Späth G; Biersack HJ
J Nucl Med; 1996 Sep; 37(9):1496-503. PubMed ID: 8790201
[TBL] [Abstract][Full Text] [Related]
29. 131-I treatment of micronodular pulmonary metastases from papillary thyroid carcinoma.
Sisson JC; Giordano TJ; Jamadar DA; Kazerooni EA; Shapiro B; Gross MD; Zempel SA; Spaulding SA
Cancer; 1996 Nov; 78(10):2184-92. PubMed ID: 8918413
[TBL] [Abstract][Full Text] [Related]
30. Gamma knife surgery in the management of brain metastases from lung carcinoma: a retrospective analysis of survival, local tumor control, and freedom from new brain metastasis.
Jawahar A; Matthew RE; Minagar A; Shukla D; Zhang JH; Willis BK; Ampil F; Nanda A
J Neurosurg; 2004 May; 100(5):842-7. PubMed ID: 15137603
[TBL] [Abstract][Full Text] [Related]
31. Comparison of post-therapeutic sequential 131I whole-body scans in the detection of metastatic thyroid cancer.
Qiu L; Tan H; Yin H; Zhou J; Cheng D; Shi H
Q J Nucl Med Mol Imaging; 2020 Sep; 64(3):313-320. PubMed ID: 30221907
[TBL] [Abstract][Full Text] [Related]
32. Anaplastic changes associated with p53 gene mutation in differentiated thyroid carcinoma after insufficient radioactive iodine (131I) therapy.
Sera N; Ashizawa K; Ando T; Ide A; Abe Y; Usa T; Tominaga T; Ejima E; Hayashi T; Shimokawa I; Eguchi K
Thyroid; 2000 Nov; 10(11):975-9. PubMed ID: 11128725
[TBL] [Abstract][Full Text] [Related]
33. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
[TBL] [Abstract][Full Text] [Related]
34. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer.
Feine U; Lietzenmayer R; Hanke JP; Held J; Wöhrle H; Müller-Schauenburg W
J Nucl Med; 1996 Sep; 37(9):1468-72. PubMed ID: 8790195
[TBL] [Abstract][Full Text] [Related]
35. [The early detection of metastatic differentiated thyroid cancer using 131I total body scan and treatment with 131I].
Ikekubo K; Hino M; Ito H; Yamaguchi H; Saiki Y; Ui K; Tominaga E; Nakanishi M; Kawai J; Koh T
Kaku Igaku; 1991 Mar; 28(3):247-59. PubMed ID: 1904509
[TBL] [Abstract][Full Text] [Related]
36. Management of childhood and adolescent thyroid carcinoma: long-term follow-up and clinical characteristics.
Okada T; Sasaki F; Takahashi H; Taguchi K; Takahashi M; Watanabe K; Itoh T; Ota S; Todo S
Eur J Pediatr Surg; 2006 Feb; 16(1):8-13. PubMed ID: 16544219
[TBL] [Abstract][Full Text] [Related]
37. Improving postoperative recurrence rates for carcinoma of the thyroid gland.
McHenry C; Jarosz H; Lawrence AM; Paloyan E
Surg Gynecol Obstet; 1989 Nov; 169(5):429-34. PubMed ID: 2814754
[TBL] [Abstract][Full Text] [Related]
38. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases.
Lin JD; Huang MJ; Juang JH; Chao TC; Huang BY; Chen KW; Chen JY; Li KL; Chen JF; Ho YS
Thyroid; 1999 Dec; 9(12):1227-35. PubMed ID: 10646663
[TBL] [Abstract][Full Text] [Related]
39. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.
Lubin E; Mechlis-Frish S; Zatz S; Shimoni A; Segal K; Avraham A; Levy R; Feinmesser R
J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995
[TBL] [Abstract][Full Text] [Related]
40. An unusual case of papillary carcinoma of the thyroid with cutaneous and breast metastases only.
Loureiro MM; Leite VH; Boavida JM; Raposo JF; Henriques MM; Limbert ES; Sobrinho LG
Eur J Endocrinol; 1997 Sep; 137(3):267-9. PubMed ID: 9330591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
